Lundbeck has issued statements discouraging the use of pentobarbital in executions.
“Lundbeck adamantly opposes the distressing misuse of our product in capital punishment,” company CEO Ulf Wiinberg said in a prepared statement Friday. “After much consideration, we have determined that a restricted distribution system is the most meaningful means through which we can restrict the misuse of Nembutal.”
The new distribution proc-ess will deny sales to corrections departments in states that impose death sentences and carry out executions.
No comments:
Post a Comment